benzoxazoles has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagah, B; Bernadat, G; Fadel, E; Guignabert, C; Huertas, A; Humbert, M; Jalce, G; Le Hiress, M; Phan, C; Simonneau, G; Thuillet, R; Tu, L | 1 |
| Li, NS; Li, T; Liu, B; Luo, XJ; Peng, J; Peng, JJ; Song, FL; Wang, EL; Yang, JF | 1 |
2 other study(ies) available for benzoxazoles and Pulmonary Hypertension
| Article | Year |
|---|---|
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Topics: Animals; Antihypertensive Agents; Benzoxazoles; Cell Line; Cell Survival; Drug Design; Fibrosis; Hypertension, Pulmonary; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; MAP Kinase Signaling System; Models, Molecular; Molecular Docking Simulation; Rats; Rats, Wistar; Structure-Activity Relationship; Thiones | 2018 |
Magnesium Lithospermate B Derived from Salvia miltiorrhiza Ameliorates Right Ventricle Remodeling in Pulmonary Hypertensive Rats via Inhibition of NOX/VPO1 Pathway.
Topics: Animals; Atrial Natriuretic Factor; Benzoxazoles; Cell Hypoxia; Cell Line; Disease Models, Animal; Drugs, Chinese Herbal; Hemeproteins; Hypertension, Pulmonary; Male; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Natriuretic Peptide, Brain; Peroxidases; Rats, Sprague-Dawley; Salvia miltiorrhiza; Triazoles; Ventricular Remodeling | 2019 |